Showing 2,930 results

Filters Content type: News, Editors' picks, About HIV Topic: PrEP

Pre-exposure prophylaxis involves people who do not have HIV taking antiretroviral drugs when they are at risk of exposure to HIV in order to prevent infection. The drugs are usually taken as pills (oral PrEP).

PrEP policies & guidelines

England: Urgent call for PrEP to be made more widely available

Editor's pick
Terrence Higgins Trust
16 November 2021
PrEP programmes & uptake

Why focusing on family could help increase young people’s PrEP use

Editor's pick
Avert
15 November 2021
Vaginal rings & topical PrEP

In Memory of Zena Stein, Public Health Pioneer, Advocate for Justice

Editor's pick
Columbia University
15 November 2021
HIV testing programmes & uptake

HIV testing and prevention services affected badly by COVID in Europe, HIV treatment less so

News
15 November 2021
Transmission & prevention

aidsmapLIVE: HIV prevention special Video

November 2021
PrEP programmes & uptake

Seasons of risk: the PrEP journey of adolescent girls and young women in Kenya and South Africa

News
8 November 2021
PrEP programmes & uptake

For long-term PrEP, we need better definitions of adherence, conference hears

News
5 November 2021
PrEP science

Kidney Toxicity Rare With Daily or On-Demand (As-Needed) PrEP

Editor's pick
NATAP
31 October 2021
Transgender people

Half of trans people attending English sexual health clinics took part in PrEP IMPACT study

News
29 October 2021
PrEP programmes & uptake

First efficacy results from England's PrEP IMPACT Trial

News
28 October 2021
PrEP policies & guidelines

Gilead Announces Decision Not to Pursue Marketing Authorization for Descovy® for Pre-Exposure Prophylaxis in the European Union

Editor's pick
Gilead press release
22 October 2021
PrEP policies & guidelines

CDC PrEP guidelines should include specific criteria for trans women

News
22 October 2021
PrEP programmes & uptake

Stark disparities seen all along the US PrEP continuum

News
21 October 2021
Confidentiality, consent & medical ethics

“Why are we being used like guinea pigs?” Transgender women’s mistrust of PrEP research

News
20 October 2021
Vaginal rings & topical PrEP

The Dapivirine Vaginal Ring: Gone far and far to go

Editor's pick
AVAC
17 October 2021
PrEP programmes & uptake

US: Racial Factors May Affect PrEP Discussions With Black Women

Editor's pick
Medscape (requires free registration)
10 October 2021
PrEP science

Islatravir Subdermal Implant for HIV PrEP Has Promising Phase 1 Trial

Editor's pick
Contagion Live
7 October 2021
Sex workers

More money, trust, and control: HIV self-testing and PrEP empowers sex workers and their partners in Uganda

News
6 October 2021
Weight gain & lipodystrophy

Older version of tenofovir used as PrEP linked to weight loss

News
5 October 2021
Combatting stigma

Ending PrEP Stigma: Researcher Calls For Integrating HIV Services Into Primary Health Care

Editor's pick
TheBodyPro
4 October 2021
PrEP science

Most switches to Descovy PrEP are probably unnecessary and some may be harmful

News
1 October 2021
PrEP programmes & uptake

Is There a PrEP-to-Primary Care Pipeline?

Editor's pick
POZ
28 September 2021
Injectable & long-acting PrEP

FDA grants Priority Review to ViiV Healthcare’s New Drug Application for cabotegravir long-acting for prevention of HIV

Editor's pick
ViiV Healthcare press release
28 September 2021
PrEP programmes & uptake

Don’t Underestimate the Benefit of HIV PrEP for Trans Women

Editor's pick
POZ
22 September 2021